The global market for Anti-Depressant was valued at US$ 15330 million in the year 2024 and is projected to reach a revised size of US$ 19180 million by 2031, growing at a CAGR of 3.3% during the forecast period.

Anti-Depressant Market

Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders. They may be prescribed alone or in combination with other medications.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-Depressant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Depressant.

The Anti-Depressant market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-Depressant market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anti-Depressant manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Anti-Depressant Market Report

Report Metric	Details
Report Name	Anti-Depressant Market
Accounted market size in year	US$ 15330 million
Forecasted market size in 2031	US$ 19180 million
CAGR	3.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Tricyclic Antidepressants Selective Serotonin Reuptake Inhibitors Serotonin-Norepinephrine Reuptake Inhibitors Monoamine Oxidase Inhibitors Serotonin Antagonist Reuptake Inhibitors Others
Segment by Application	Major Depressive Disorder Obsessive-Compulsive Disorder Generalized Anxiety Disorder Panic Disorder Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Alkermes, Allergan, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Lundbeck, Merck, Pfizer, Teva Pharmaceutical Industries, Takeda Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-Depressant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-Depressant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Anti-Depressant Market growing?

Ans: The Anti-Depressant Market witnessing a CAGR of 3.3% during the forecast period 2025-2031.

What is the Anti-Depressant Market size in 2031?

Ans: The Anti-Depressant Market size in 2031 will be US$ 19180 million.

Who are the main players in the Anti-Depressant Market report?

Ans: The main players in the Anti-Depressant Market are Alkermes, Allergan, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Lundbeck, Merck, Pfizer, Teva Pharmaceutical Industries, Takeda Pharmaceutical

What are the Application segmentation covered in the Anti-Depressant Market report?

Ans: The Applications covered in the Anti-Depressant Market report are Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, Others

What are the Type segmentation covered in the Anti-Depressant Market report?

Ans: The Types covered in the Anti-Depressant Market report are Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Serotonin Antagonist, Reuptake Inhibitors, Others

1 Anti-Depressant Market Overview

1.1 Product Definition

1.2 Anti-Depressant by Type

1.2.1 Global Anti-Depressant Market Value Comparison by Type (2024 VS 2031)

1.2.2 Tricyclic Antidepressants

1.2.3 Selective Serotonin Reuptake Inhibitors

1.2.4 Serotonin-Norepinephrine Reuptake Inhibitors

1.2.5 Monoamine Oxidase Inhibitors

1.2.6 Serotonin Antagonist

1.2.7 Reuptake Inhibitors

1.2.8 Others

1.3 Anti-Depressant by Application

1.3.1 Global Anti-Depressant Market Value by Application (2024 VS 2031)

1.3.2 Major Depressive Disorder

1.3.3 Obsessive-Compulsive Disorder

1.3.4 Generalized Anxiety Disorder

1.3.5 Panic Disorder

1.3.6 Others

1.4 Global Anti-Depressant Market Size Estimates and Forecasts

1.4.1 Global Anti-Depressant Revenue 2020-2031

1.4.2 Global Anti-Depressant Sales 2020-2031

1.4.3 Global Anti-Depressant Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Anti-Depressant Market Competition by Manufacturers

2.1 Global Anti-Depressant Sales Market Share by Manufacturers (2020-2025)

2.2 Global Anti-Depressant Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Anti-Depressant Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Anti-Depressant, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Anti-Depressant, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Anti-Depressant, Product Type & Application

2.7 Global Key Manufacturers of Anti-Depressant, Date of Enter into This Industry

2.8 Global Anti-Depressant Market Competitive Situation and Trends

2.8.1 Global Anti-Depressant Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Anti-Depressant Players Market Share by Revenue

2.8.3 Global Anti-Depressant Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Anti-Depressant Market Scenario by Region

3.1 Global Anti-Depressant Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Anti-Depressant Sales by Region: 2020-2031

3.2.1 Global Anti-Depressant Sales by Region: 2020-2025

3.2.2 Global Anti-Depressant Sales by Region: 2026-2031

3.3 Global Anti-Depressant Revenue by Region: 2020-2031

3.3.1 Global Anti-Depressant Revenue by Region: 2020-2025

3.3.2 Global Anti-Depressant Revenue by Region: 2026-2031

3.4 North America Anti-Depressant Market Facts & Figures by Country

3.4.1 North America Anti-Depressant Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Anti-Depressant Sales by Country (2020-2031)

3.4.3 North America Anti-Depressant Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Anti-Depressant Market Facts & Figures by Country

3.5.1 Europe Anti-Depressant Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Anti-Depressant Sales by Country (2020-2031)

3.5.3 Europe Anti-Depressant Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Anti-Depressant Market Facts & Figures by Region

3.6.1 Asia Pacific Anti-Depressant Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Anti-Depressant Sales by Region (2020-2031)

3.6.3 Asia Pacific Anti-Depressant Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Anti-Depressant Market Facts & Figures by Country

3.7.1 Latin America Anti-Depressant Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Anti-Depressant Sales by Country (2020-2031)

3.7.3 Latin America Anti-Depressant Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Anti-Depressant Market Facts & Figures by Country

3.8.1 Middle East and Africa Anti-Depressant Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Anti-Depressant Sales by Country (2020-2031)

3.8.3 Middle East and Africa Anti-Depressant Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Anti-Depressant Sales by Type (2020-2031)

4.1.1 Global Anti-Depressant Sales by Type (2020-2025)

4.1.2 Global Anti-Depressant Sales by Type (2026-2031)

4.1.3 Global Anti-Depressant Sales Market Share by Type (2020-2031)

4.2 Global Anti-Depressant Revenue by Type (2020-2031)

4.2.1 Global Anti-Depressant Revenue by Type (2020-2025)

4.2.2 Global Anti-Depressant Revenue by Type (2026-2031)

4.2.3 Global Anti-Depressant Revenue Market Share by Type (2020-2031)

4.3 Global Anti-Depressant Price by Type (2020-2031)

5 Segment by Application

5.1 Global Anti-Depressant Sales by Application (2020-2031)

5.1.1 Global Anti-Depressant Sales by Application (2020-2025)

5.1.2 Global Anti-Depressant Sales by Application (2026-2031)

5.1.3 Global Anti-Depressant Sales Market Share by Application (2020-2031)

5.2 Global Anti-Depressant Revenue by Application (2020-2031)

5.2.1 Global Anti-Depressant Revenue by Application (2020-2025)

5.2.2 Global Anti-Depressant Revenue by Application (2026-2031)

5.2.3 Global Anti-Depressant Revenue Market Share by Application (2020-2031)

5.3 Global Anti-Depressant Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Alkermes

6.1.1 Alkermes Company Information

6.1.2 Alkermes Description and Business Overview

6.1.3 Alkermes Anti-Depressant Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Alkermes Anti-Depressant Product Portfolio

6.1.5 Alkermes Recent Developments/Updates

6.2 Allergan

6.2.1 Allergan Company Information

6.2.2 Allergan Description and Business Overview

6.2.3 Allergan Anti-Depressant Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Allergan Anti-Depressant Product Portfolio

6.2.5 Allergan Recent Developments/Updates

6.3 Bristol-Myers Squibb

6.3.1 Bristol-Myers Squibb Company Information

6.3.2 Bristol-Myers Squibb Description and Business Overview

6.3.3 Bristol-Myers Squibb Anti-Depressant Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Bristol-Myers Squibb Anti-Depressant Product Portfolio

6.3.5 Bristol-Myers Squibb Recent Developments/Updates

6.4 Eli Lilly and Company

6.4.1 Eli Lilly and Company Company Information

6.4.2 Eli Lilly and Company Description and Business Overview

6.4.3 Eli Lilly and Company Anti-Depressant Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Eli Lilly and Company Anti-Depressant Product Portfolio

6.4.5 Eli Lilly and Company Recent Developments/Updates

6.5 GlaxoSmithKline

6.5.1 GlaxoSmithKline Company Information

6.5.2 GlaxoSmithKline Description and Business Overview

6.5.3 GlaxoSmithKline Anti-Depressant Sales, Revenue and Gross Margin (2020-2025)

6.5.4 GlaxoSmithKline Anti-Depressant Product Portfolio

6.5.5 GlaxoSmithKline Recent Developments/Updates

6.6 Lundbeck

6.6.1 Lundbeck Company Information

6.6.2 Lundbeck Description and Business Overview

6.6.3 Lundbeck Anti-Depressant Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Lundbeck Anti-Depressant Product Portfolio

6.6.5 Lundbeck Recent Developments/Updates

6.7 Merck

6.7.1 Merck Company Information

6.7.2 Merck Description and Business Overview

6.7.3 Merck Anti-Depressant Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Merck Anti-Depressant Product Portfolio

6.7.5 Merck Recent Developments/Updates

6.8 Pfizer

6.8.1 Pfizer Company Information

6.8.2 Pfizer Description and Business Overview

6.8.3 Pfizer Anti-Depressant Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Pfizer Anti-Depressant Product Portfolio

6.8.5 Pfizer Recent Developments/Updates

6.9 Teva Pharmaceutical Industries

6.9.1 Teva Pharmaceutical Industries Company Information

6.9.2 Teva Pharmaceutical Industries Description and Business Overview

6.9.3 Teva Pharmaceutical Industries Anti-Depressant Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Teva Pharmaceutical Industries Anti-Depressant Product Portfolio

6.9.5 Teva Pharmaceutical Industries Recent Developments/Updates

6.10 Takeda Pharmaceutical

6.10.1 Takeda Pharmaceutical Company Information

6.10.2 Takeda Pharmaceutical Description and Business Overview

6.10.3 Takeda Pharmaceutical Anti-Depressant Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Takeda Pharmaceutical Anti-Depressant Product Portfolio

6.10.5 Takeda Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Anti-Depressant Industry Chain Analysis

7.2 Anti-Depressant Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Anti-Depressant Production Mode & Process Analysis

7.4 Anti-Depressant Sales and Marketing

7.4.1 Anti-Depressant Sales Channels

7.4.2 Anti-Depressant Distributors

7.5 Anti-Depressant Customer Analysis

8 Anti-Depressant Market Dynamics

8.1 Anti-Depressant Industry Trends

8.2 Anti-Depressant Market Drivers

8.3 Anti-Depressant Market Challenges

8.4 Anti-Depressant Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Alkermes plc

Allergan plc

Bristol–Myers Squibb

Eli Lilly and Company

Teva Pharmaceutical Industries

Takeda Pharmaceutical

List of Tables

Table 1. Global Anti-Depressant Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Anti-Depressant Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Anti-Depressant Market Competitive Situation by Manufacturers in 2024

Table 4. Global Anti-Depressant Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Anti-Depressant Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Anti-Depressant Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Anti-Depressant Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Anti-Depressant Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Anti-Depressant, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Anti-Depressant, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Anti-Depressant, Product Type & Application

Table 12. Global Key Manufacturers of Anti-Depressant, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Anti-Depressant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Depressant as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Anti-Depressant Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Anti-Depressant Sales by Region (2020-2025) & (K Units)

Table 18. Global Anti-Depressant Sales Market Share by Region (2020-2025)

Table 19. Global Anti-Depressant Sales by Region (2026-2031) & (K Units)

Table 20. Global Anti-Depressant Sales Market Share by Region (2026-2031)

Table 21. Global Anti-Depressant Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Anti-Depressant Revenue Market Share by Region (2020-2025)

Table 23. Global Anti-Depressant Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Anti-Depressant Revenue Market Share by Region (2026-2031)

Table 25. North America Anti-Depressant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Anti-Depressant Sales by Country (2020-2025) & (K Units)

Table 27. North America Anti-Depressant Sales by Country (2026-2031) & (K Units)

Table 28. North America Anti-Depressant Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Anti-Depressant Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Anti-Depressant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Anti-Depressant Sales by Country (2020-2025) & (K Units)

Table 32. Europe Anti-Depressant Sales by Country (2026-2031) & (K Units)

Table 33. Europe Anti-Depressant Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Anti-Depressant Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Anti-Depressant Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Anti-Depressant Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Anti-Depressant Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Anti-Depressant Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Anti-Depressant Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Anti-Depressant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Anti-Depressant Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Anti-Depressant Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Anti-Depressant Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Anti-Depressant Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Anti-Depressant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Anti-Depressant Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Anti-Depressant Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Anti-Depressant Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Anti-Depressant Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Anti-Depressant Sales (K Units) by Type (2020-2025)

Table 51. Global Anti-Depressant Sales (K Units) by Type (2026-2031)

Table 52. Global Anti-Depressant Sales Market Share by Type (2020-2025)

Table 53. Global Anti-Depressant Sales Market Share by Type (2026-2031)

Table 54. Global Anti-Depressant Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Anti-Depressant Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Anti-Depressant Revenue Market Share by Type (2020-2025)

Table 57. Global Anti-Depressant Revenue Market Share by Type (2026-2031)

Table 58. Global Anti-Depressant Price (USD/Unit) by Type (2020-2025)

Table 59. Global Anti-Depressant Price (USD/Unit) by Type (2026-2031)

Table 60. Global Anti-Depressant Sales (K Units) by Application (2020-2025)

Table 61. Global Anti-Depressant Sales (K Units) by Application (2026-2031)

Table 62. Global Anti-Depressant Sales Market Share by Application (2020-2025)

Table 63. Global Anti-Depressant Sales Market Share by Application (2026-2031)

Table 64. Global Anti-Depressant Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Anti-Depressant Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Anti-Depressant Revenue Market Share by Application (2020-2025)

Table 67. Global Anti-Depressant Revenue Market Share by Application (2026-2031)

Table 68. Global Anti-Depressant Price (USD/Unit) by Application (2020-2025)

Table 69. Global Anti-Depressant Price (USD/Unit) by Application (2026-2031)

Table 70. Alkermes Company Information

Table 71. Alkermes Description and Business Overview

Table 72. Alkermes Anti-Depressant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Alkermes Anti-Depressant Product

Table 74. Alkermes Recent Developments/Updates

Table 75. Allergan Company Information

Table 76. Allergan Description and Business Overview

Table 77. Allergan Anti-Depressant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Allergan Anti-Depressant Product

Table 79. Allergan Recent Developments/Updates

Table 80. Bristol-Myers Squibb Company Information

Table 81. Bristol-Myers Squibb Description and Business Overview

Table 82. Bristol-Myers Squibb Anti-Depressant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Bristol-Myers Squibb Anti-Depressant Product

Table 84. Bristol-Myers Squibb Recent Developments/Updates

Table 85. Eli Lilly and Company Company Information

Table 86. Eli Lilly and Company Description and Business Overview

Table 87. Eli Lilly and Company Anti-Depressant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Eli Lilly and Company Anti-Depressant Product

Table 89. Eli Lilly and Company Recent Developments/Updates

Table 90. GlaxoSmithKline Company Information

Table 91. GlaxoSmithKline Description and Business Overview

Table 92. GlaxoSmithKline Anti-Depressant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. GlaxoSmithKline Anti-Depressant Product

Table 94. GlaxoSmithKline Recent Developments/Updates

Table 95. Lundbeck Company Information

Table 96. Lundbeck Description and Business Overview

Table 97. Lundbeck Anti-Depressant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Lundbeck Anti-Depressant Product

Table 99. Lundbeck Recent Developments/Updates

Table 100. Merck Company Information

Table 101. Merck Description and Business Overview

Table 102. Merck Anti-Depressant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Merck Anti-Depressant Product

Table 104. Merck Recent Developments/Updates

Table 105. Pfizer Company Information

Table 106. Pfizer Description and Business Overview

Table 107. Pfizer Anti-Depressant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Pfizer Anti-Depressant Product

Table 109. Pfizer Recent Developments/Updates

Table 110. Teva Pharmaceutical Industries Company Information

Table 111. Teva Pharmaceutical Industries Description and Business Overview

Table 112. Teva Pharmaceutical Industries Anti-Depressant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Teva Pharmaceutical Industries Anti-Depressant Product

Table 114. Teva Pharmaceutical Industries Recent Developments/Updates

Table 115. Takeda Pharmaceutical Company Information

Table 116. Takeda Pharmaceutical Description and Business Overview

Table 117. Takeda Pharmaceutical Anti-Depressant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Takeda Pharmaceutical Anti-Depressant Product

Table 119. Takeda Pharmaceutical Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Anti-Depressant Distributors List

Table 123. Anti-Depressant Customers List

Table 124. Anti-Depressant Market Trends

Table 125. Anti-Depressant Market Drivers

Table 126. Anti-Depressant Market Challenges

Table 127. Anti-Depressant Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Anti-Depressant

Figure 2. Global Anti-Depressant Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Anti-Depressant Market Share by Type: 2024 & 2031

Figure 4. Tricyclic Antidepressants Product Picture

Figure 5. Selective Serotonin Reuptake Inhibitors Product Picture

Figure 6. Serotonin-Norepinephrine Reuptake Inhibitors Product Picture

Figure 7. Monoamine Oxidase Inhibitors Product Picture

Figure 8. Serotonin Antagonist Product Picture

Figure 9. Reuptake Inhibitors Product Picture

Figure 10. Others Product Picture

Figure 11. Global Anti-Depressant Market Value by Application (2020-2031) & (US$ Million)

Figure 12. Global Anti-Depressant Market Share by Application: 2024 & 2031

Figure 13. Major Depressive Disorder

Figure 14. Obsessive-Compulsive Disorder

Figure 15. Generalized Anxiety Disorder

Figure 16. Panic Disorder

Figure 17. Others

Figure 18. Global Anti-Depressant Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Anti-Depressant Market Size (2020-2031) & (US$ Million)

Figure 20. Global Anti-Depressant Sales (2020-2031) & (K Units)

Figure 21. Global Anti-Depressant Average Price (USD/Unit) & (2020-2031)

Figure 22. Anti-Depressant Report Years Considered

Figure 23. Anti-Depressant Sales Share by Manufacturers in 2024

Figure 24. Global Anti-Depressant Revenue Share by Manufacturers in 2024

Figure 25. Global 5 and 10 Largest Anti-Depressant Players: Market Share by Revenue in Anti-Depressant in 2024

Figure 26. Anti-Depressant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 27. Global Anti-Depressant Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 28. North America Anti-Depressant Sales Market Share by Country (2020-2031)

Figure 29. North America Anti-Depressant Revenue Market Share by Country (2020-2031)

Figure 30. U.S. Anti-Depressant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Canada Anti-Depressant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Europe Anti-Depressant Sales Market Share by Country (2020-2031)

Figure 33. Europe Anti-Depressant Revenue Market Share by Country (2020-2031)

Figure 34. Germany Anti-Depressant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. France Anti-Depressant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. U.K. Anti-Depressant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Italy Anti-Depressant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Russia Anti-Depressant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Asia Pacific Anti-Depressant Sales Market Share by Region (2020-2031)

Figure 40. Asia Pacific Anti-Depressant Revenue Market Share by Region (2020-2031)

Figure 41. China Anti-Depressant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Japan Anti-Depressant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. South Korea Anti-Depressant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. India Anti-Depressant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Australia Anti-Depressant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Taiwan Anti-Depressant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Indonesia Anti-Depressant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Thailand Anti-Depressant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Malaysia Anti-Depressant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Philippines Anti-Depressant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Latin America Anti-Depressant Sales Market Share by Country (2020-2031)

Figure 52. Latin America Anti-Depressant Revenue Market Share by Country (2020-2031)

Figure 53. Mexico Anti-Depressant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Brazil Anti-Depressant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Argentina Anti-Depressant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Middle East and Africa Anti-Depressant Sales Market Share by Country (2020-2031)

Figure 57. Middle East and Africa Anti-Depressant Revenue Market Share by Country (2020-2031)

Figure 58. Turkey Anti-Depressant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 59. Saudi Arabia Anti-Depressant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 60. U.A.E Anti-Depressant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 61. Global Sales Market Share of Anti-Depressant by Type (2020-2031)

Figure 62. Global Revenue Market Share of Anti-Depressant by Type (2020-2031)

Figure 63. Global Anti-Depressant Price (USD/Unit) by Type (2020-2031)

Figure 64. Global Sales Market Share of Anti-Depressant by Application (2020-2031)

Figure 65. Global Revenue Market Share of Anti-Depressant by Application (2020-2031)

Figure 66. Global Anti-Depressant Price (USD/Unit) by Application (2020-2031)

Figure 67. Anti-Depressant Value Chain

Figure 68. Channels of Distribution (Direct Vs Distribution)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions